Current Assets
Cash & Equivalents
Elevance Health Cash & Equivalents increased by 1.7% to $9.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.8%, from $7.5B to $9.66B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 10.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ1 2026Apr 22, 2026
How to read this metric
An increase suggests strong liquidity and capacity for investment or acquisitions, while a decrease may indicate heavy capital deployment or cash flow pressure.
Detailed definition
This represents the most liquid assets held by the company, including currency, demand deposits, and short-term investme...
Peer comparison
Peers in the managed care industry typically maintain significant cash balances to satisfy regulatory capital requirements and claims payment cycles.
Metric ID:
cash_and_equivalentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.26B | $5.49B | $4.88B | $6.16B | $6.46B | $8.87B | $7.39B | $10.14B | $9.99B | $10.92B | $6.53B | $6.23B | $6.5B | $7.87B | $8.29B | $7.5B | $8.56B | $8.71B | $9.49B | $9.66B |
| QoQ Change | — | +4.4% | -11.1% | +26.3% | +4.8% | +37.4% | -16.7% | +37.3% | -1.5% | +9.3% | -40.2% | -4.6% | +4.4% | +21.1% | +5.4% | -9.5% | +14.1% | +1.8% | +8.9% | +1.7% |
| YoY Change | — | — | — | — | +22.8% | +61.6% | +51.4% | +64.6% | +54.8% | +23.1% | -11.7% | -38.6% | -35.0% | -28.0% | +27.0% | +20.5% | +31.8% | +10.8% | +14.5% | +28.8% |
Range$4.88B – $10.92B
CAGR+13.7%
Avg YoY Growth+18.6%
Median YoY Growth+22.9%
Current Streak4 quarters growth
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Elevance Health's cash & equivalents?
- Elevance Health (ELV) reported cash & equivalents of $9.66B in Q1 2026.
- How has Elevance Health's cash & equivalents changed year-over-year?
- Elevance Health's cash & equivalents increased by 28.8% year-over-year, from $7.5B to $9.66B.
- What is the long-term trend for Elevance Health's cash & equivalents?
- Over 5 years (2020 to 2025), Elevance Health's cash & equivalents has grown at a 10.6% compound annual growth rate (CAGR), from $5.74B to $9.49B.
- What does cash & equivalents mean?
- The total value of cash and highly liquid investments that can be converted to cash within 90 days.